Fixing the NHS waiting list

Opportunity: Dedicated surgical hubs to provide high-volume, low-complexity elective care, addressing the NHS backlog of over 7.5 million patients waiting for procedures.

Market: There is significant unmet demand within the UK healthcare sector, requiring an additional 40,000 operations weekly to maintain current waiting times.

Competitive Advantage: A specialised focus on elective surgeries enables greater efficiency compared to general hospitals, supported by partnerships with NHS Integrated Care Boards.

Strategic Focus: Initial roll-out of surgical hubs in Greater Manchester, with planned expansion across the North West. Collaboration with NHS trusts and local healthcare providers ensures streamlined service delivery.

Investment required: Funding the establishment of surgical hubs, scaling operations, and creating a replicable model to address national demand.

  • Location: UK (North West)

  • Sector: Healthcare

  • Investment Sought: £6,200,000

  • Equity Offered: 40%

The Business: The company aims to alleviate NHS pressures by creating a network of specialised clinics focused on elective surgeries. These clinics address high-volume, low-complexity operations, providing patients with faster and more accessible care. The model prioritises simplicity and scale, delivering high-impact results for patients and communities.

The Market: The NHS's current backlog of elective surgeries presents a critical challenge, with over 7.5 million patients awaiting treatment. This company’s focus on Greater Manchester and surrounding areas offers a targeted response to regions most affected by long waiting times. The business aims to fill a critical gap in healthcare provision by delivering cost-effective, efficient care.

Growth projections underline the potential for significant impact and scalability. The initial model is designed to be expanded across other underserved regions in the UK.

The Competition: The primary competitors are private healthcare providers in the UK. However, this company’s focus on elective surgeries provides a niche offering that differs from broader-spectrum services. By collaborating directly with NHS Integrated Care Boards, the company achieves cost efficiency and operational focus unmatched by its competitors.

Traction and Achievements:

  • Team Expertise: Led by experienced healthcare professionals with a strong track record in operational delivery and NHS collaboration.

  • Operational Milestones: Secured partnerships with healthcare providers for seamless roll-out.

  • Expansion Strategy: Three clinics planned in key underserved regions, with phased growth upon achieving initial milestones.

 
Growth & Futures Prospects:
Key growth opportunities include:

  • Addressing rising demand due to NHS backlogs.

  • Scaling the model across other underserved regions in the UK.

  • Expanding partnerships with private insurers and healthcare groups.

Exit strategies include acquisition by a larger private healthcare provider or consolidation with similar elective care clinics, offering significant potential returns for investors.

Risk Warning
Investing in early-stage businesses involves significant risks, including illiquidity, loss of investment, and dilution. Investments of this nature should be part of a diversified portfolio. These opportunities are not covered by the Financial Services Compensation Scheme (FSCS). Seek independent financial advice before proceeding.